Could a simple shot replace IV blood thinners for ECMO patients?
NCT ID NCT04496362
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests if giving the blood thinner heparin as a shot under the skin is as safe and effective as the standard method of giving it through an IV for adults on ECMO (a machine that helps the lungs). The goal is to see if the shot method causes fewer bleeding or clotting problems. About 100 participants will be randomly assigned to one of the two approaches.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ECMO are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor Scott & White Health research institute
Dallas, Texas, 75246, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal cord zap may help people breathe again after neck injury
- Tweaking ventilator settings could ease breathlessness and cut PTSD risk in ICU survivors
- AI could predict the perfect moment to take ICU patients off ventilators
- Could a watchful software save ICU patients from organ failure?
- New anxiety program for ICU survivors shows promise in early trial
- New blood thinning combo could cut ECMO bleeding and clotting risks